HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerd Horneff Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

1/2022Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial.
1/2022Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis.
11/2021Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study.
10/2021Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
4/2021Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry.
3/2021Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry.
1/2021Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis.
1/2021Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study.
10/2020Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry.
10/2020Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerd Horneff Research Topics

Disease

68Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2022 - 04/2004
17Arthritis (Polyarthritis)
02/2022 - 04/2004
9Uveitis
01/2022 - 05/2007
9Infections
04/2021 - 01/2004
7Inflammation (Inflammations)
01/2022 - 04/2004
6Psoriatic Arthritis
08/2019 - 03/2013
6Rheumatic Diseases (Rheumatism)
01/2019 - 04/2005
5Body Weight (Weight, Body)
12/2017 - 05/2004
4Neoplasms (Cancer)
10/2020 - 01/2011
3Pain (Aches)
01/2022 - 01/2014
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2020 - 07/2011
3Macrophage Activation Syndrome
01/2020 - 12/2012
3Cryopyrin-Associated Periodic Syndromes
11/2019 - 12/2010
3Arthralgia (Joint Pain)
08/2019 - 05/2004
3Rheumatoid Arthritis
06/2015 - 04/2005
2Dermatomyositis (Dermatopolymyositis)
02/2022 - 01/2020
2Injection Site Reaction
11/2021 - 01/2018
2Necrosis
04/2021 - 02/2007
2Herpes Zoster
10/2020 - 08/2002
2Cytopenia
01/2020 - 01/2020
2Psoriasis (Pustulosis Palmaris et Plantaris)
08/2019 - 10/2018
2Fever (Fevers)
01/2018 - 12/2012
2Drug-Related Side Effects and Adverse Reactions
11/2015 - 11/2014
2Ankylosing Spondylitis
10/2012 - 05/2004
2Incontinentia Pigmenti (Bloch Sulzberger Syndrome)
04/2006 - 12/2004
2Ectodermal Dysplasia (Aplasia Cutis Congenita)
04/2006 - 12/2004
1Sacroiliitis
02/2022
1Myositis (Idiopathic Inflammatory Myopathies)
02/2022
1Muscle Weakness
02/2022
1Spondylarthritis (Spinal Arthritis)
02/2022
1Opportunistic Infections (Opportunistic Infection)
04/2021
1Communicable Diseases (Infectious Diseases)
04/2021
1Glucose Intolerance
01/2021
1Pulmonary Alveolar Proteinosis
01/2020
1Premature Birth (Birth, Premature)
01/2020
1Disease Progression
01/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
08/2019
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
08/2019
1Rheumatoid Nodule
08/2019
1Tuberculosis (Tuberculoses)
08/2019
1Adult-Onset Still's Disease
01/2019
1Neutropenia
01/2019
1Crohn Disease (Crohn's Disease)
10/2018

Drug/Important Bio-Agent (IBA)

27Etanercept (Enbrel)FDA Link
11/2021 - 02/2007
21Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 04/2005
15Biological ProductsIBA
01/2021 - 03/2013
11Adalimumab (Humira)FDA Link
10/2020 - 08/2008
8tocilizumab (atlizumab)FDA Link
10/2021 - 06/2015
8Interleukin-1 (Interleukin 1)IBA
04/2021 - 12/2010
7canakinumabFDA Link
01/2021 - 12/2012
7Antirheumatic Agents (DMARD)IBA
01/2021 - 06/2010
6C-Reactive ProteinIBA
01/2022 - 12/2012
6Tumor Necrosis Factor InhibitorsIBA
01/2017 - 12/2009
5Pharmaceutical PreparationsIBA
01/2022 - 04/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 05/2004
4Adrenal Cortex Hormones (Corticosteroids)IBA
04/2021 - 07/2014
4Abatacept (Orencia)FDA Link
04/2021 - 06/2010
4Infliximab (Remicade)FDA Link
11/2015 - 05/2004
3AutoantibodiesIBA
02/2022 - 12/2015
3Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2014
3S100A12 ProteinIBA
01/2022 - 04/2004
3Interleukin-6 (Interleukin 6)IBA
04/2021 - 01/2015
3CytokinesIBA
03/2021 - 12/2010
3Transaminases (Aminotransferases)IBA
01/2020 - 09/2005
3Antinuclear AntibodiesIBA
08/2019 - 11/2015
3Proteins (Proteins, Gene)FDA Link
08/2009 - 04/2004
2SteroidsIBA
01/2020 - 01/2015
2Interleukin-18 (Interleukin 18)IBA
01/2020 - 01/2019
2Rheumatoid FactorIBA
08/2019 - 11/2015
2Anti-Bacterial Agents (Antibiotics)IBA
08/2019 - 12/2004
2Synthetic DrugsIBA
12/2018 - 01/2016
2GlucocorticoidsIBA
01/2018 - 12/2012
2golimumabFDA Link
01/2018 - 11/2015
2Leflunomide (Arava)FDA LinkGeneric
01/2016 - 04/2005
2AntigensIBA
12/2015 - 12/2009
2AntibodiesIBA
12/2015 - 09/2008
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
08/2009 - 12/2007
2NF-kappa B (NF-kB)IBA
04/2006 - 12/2004
2Intravenous Immunoglobulins (IVIG)FDA Link
12/2004 - 01/2004
1spiropentaneacetic acid (SPAA)IBA
02/2022
1Creatine Kinase (Creatine Phosphokinase)IBA
02/2022
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1N-phthaloylglutamic acidIBA
01/2022
1Biosimilar PharmaceuticalsIBA
11/2021
1InterleukinsIBA
04/2021
1Interleukin-6 InhibitorsIBA
04/2021
1Human Growth Hormone (Saizen)FDA LinkGeneric
01/2021
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2020
1Anti-Citrullinated Protein AntibodiesIBA
08/2019
1baricitinibIBA
08/2019
1Vitamin DFDA LinkGeneric
12/2018
1hydroxide ionIBA
12/2018

Therapy/Procedure

25Therapeutics
01/2022 - 01/2004
5Biological Therapy
01/2020 - 09/2012
2Premedication
04/2021 - 01/2017
1Cesarean Section (Caesarean Section)
01/2020
1Drug Therapy (Chemotherapy)
09/2019
1Complementary Therapies (Alternative Medicine)
08/2019
1Tonsillectomy
08/2019